Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COPPER study of early dexamethasone for deteriorating COVID-19 in primary care
NL-OMON50987Phase 4Completed
- Sponsor
- General Practitioners Research Institute
- Start
- Feb 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dexamethasone in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by General Practitioners Research Institute. Primary endpoint: Time to first hospital admission. Started Feb 2021; status: completed.
02
Drugs
dexamethasone
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NL-OMON50987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50987.